{"version":"1.0","provider_name":"Market Newsdesk","provider_url":"https:\/\/www.marketnewsdesk.com","author_name":"Newsdesk","author_url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/","title":"Selvita to acquire Fidelta from Galapagos - Market Newsdesk","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"d62yN5Kvyg\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/selvita-to-acquire-fidelta-from-galapagos\/\">Selvita to acquire Fidelta from Galapagos<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.marketnewsdesk.com\/index.php\/selvita-to-acquire-fidelta-from-galapagos\/embed\/#?secret=d62yN5Kvyg\" width=\"600\" height=\"338\" title=\"&#8220;Selvita to acquire Fidelta from Galapagos&#8221; &#8212; Market Newsdesk\" data-secret=\"d62yN5Kvyg\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.marketnewsdesk.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"-Strengthening Selvita\u2019s position as one of the largest preclinical contract research organizations in Europe &#8211; Acquisition substantially expands Selvita\u2019s integrated drug discovery services offering Transaction will almost double Selvita\u2019s revenues Enterprise value of \u20ac 31.2M\u00a0 to be paid in cash Fidelta to continue performing drug discovery services for Galapagos for the next five years Mechelen, Belgium and Krakow, Poland \u2013 23 November 2020, 22.15 CET \u2013 Galapagos NV [Euronext &amp; NASDAQ: GLPG] and Selvita S.A. [WSE: SLV] \u2013 announced today that they have signed an agreement under which Selvita will acquire 100% of the outstanding shares in Fidelta d.o.o. for an enterprise value of \u20ac 31.2M plus the customary adjustments for net cash and working capital. Fidelta is a contract &hellip; Continue reading \"\"","thumbnail_url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0MDkzNSM0MDA4MjUzMTkjMjAwMDI4NA=="}